// App-Quantinova.ai

1190 : Lifestyle risk factors for non-valvular atrial fibrillation

Researchers

Presenter

  • C.A. Buzea

Principal Investigators

  • L. Pagliani

  • T. Gregorio

  • M. Santos

  • R. Providencia

  • J.I. Weitz

  • C. Wallenhorst

  • C. Martinez

  • A.T. Cohen

Medical Centers

  • University of Medicine and Pharmacy Carol Davila, Colentina Clinical Hospital, Bucharest, Romania

  • University of Padova, Motta di Livenza High Specialization Rehabilitation Hospital, Padua, Italy

  • Hospital Center of Vila Nova de Gaia/Espinho, Department of Cardiology, Vila Nova de Gaia, Portugal

  • Faculty of Medicine, University of Porto, , Portugal

  • Barts Health NHS Trust, London, United Kingdom

  • McMaster University, Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada

  • Institute for Epidemiology, Statistics and Informatics, Frankfurt, Germany

  • King's College Hospital, Department of Haematological Medicine, Guys and St Thomas' NHS Foundation Trust, London, United Kingdom

Locations

  • Romania

  • Italy

  • Portugal

  • United Kingdom

  • Canada

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxyzine

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Bayer Zydus Pharma Private Limited

Result

  • N/A